Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home Exercise + Corticosteroid Injection for Greater Trochanteric Pain Syndrome
NCT06456099Completed
- Sponsor
- Aalborg University
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of Corticosteroid lotion in greater trochanteric pain syndrome (GTPS), sponsored by Aalborg University. Primary endpoints: Acceptability of performing our exercise program at 8 weeks, Acceptability of performing exercises after receiving a corticosteroid injection at 8 weeks and 1 more. Started Jun 2024; status: completed.
02
Drugs
Corticosteroid lotion
03
Conditions
greater trochanteric pain syndrome (GTPS)
Beyond the preview
Go deeper on NCT06456099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06456099.